Status | Study |
Recruiting |
Study Name: Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer Condition: Adnexal Mass Borderline Ovarian Epithelial Tumor Date: 2015-07-30 Interventions: Drug: Dexamethasone Given PO |
Completed |
Study Name: Collecting Tumor Samples From Patients With Gynecological Tumors Condition: Borderline Ovarian Clear Cell Tumor Borderline Ovarian Serous Tumor Date: 2009-05-09 Interventions: Other: Laboratory Biomarker Analysis Correlative studies |
Completed |
Study Name: External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Condition: Cancer Date: 2008-03-14 Interventions: Drug: indinavir sulfate Drug: ritonavir |
Active, not recruiting |
Study Name: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer Condition: Borderline Ovarian Surface Epithelial-stromal Tumor Ovarian Ser Date: 2007-10-22 Interventions: Drug: selumetinib Given PO |
Completed |
Study Name: Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer Condition: Cervical Cancer Ovarian Cancer Sarcoma Date: 2006-09-29 Interventions: Other: counseling intervention Other: stud |
Completed |
Study Name: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer Condition: Cervical Cancer Endometrial Cancer Fallopian Tube Cancer Date: 2006-09-26 Interventions: Drug: fondaparinux sodium Fondaparinux, 2.5 mg subcutaneous, Days 1-28 by mouth. |
Completed |
Study Name: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors Condition: Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Recu Date: 2006-03-09 Interventions: Drug: Belinostat Given IV |
Completed |
Study Name: Gefitinib in Treating Patients With Cervical Cancer Condition: Cervical Cancer Fallopian Tube Cancer Ovarian Cancer Date: 2002-11-12 Interventions: Drug: gefitinib Other: immunohistochemistr |
Completed |
Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer Condition: Cancer Date: 2002-09-06 Interventions: Drug: vorinostat |
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor Condition: Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Ca Date: 2002-06-06 Interventions: Drug: imatinib mesylate |